9780309993821 - aligning investments in therapeutic development with therapeutic need: closing the gap von national academies of sciences engineering and medicine; health and medicine division; board of health care services; committee on strategies to better align investments in innovations for therapeutic development with disease burden and unmet needs (18 Ergebnisse)
- Softcover
Anbieter: Books From California, Simi Valley, CA, USABooks From California
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Sehr gut
EUR 4,41
EUR 4,27 VersandVersand innerhalb von USAAnzahl: 7 verfügbar
paperback. Zustand: Fine.
- Softcover
Anbieter: Books From California, Simi Valley, CA, USABooks From California
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Gebraucht - Gut
EUR 4,41
EUR 4,27 VersandVersand innerhalb von USAAnzahl: 2 verfügbar
paperback. Zustand: Very Good. Cover and edges may have some wear.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: GreatBookPrices, Columbia, MD, USAGreatBookPrices
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 24,81
EUR 2,26 VersandVersand innerhalb von USAAnzahl: 3 verfügbar
Zustand: New.
Aligning Investments in Therapeutic Development with Therapeutic Need
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 27,15
Versand gratisVersand innerhalb von USAAnzahl: 2 verfügbar
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: GreatBookPrices, Columbia, MD, USAGreatBookPrices
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 26,21
EUR 2,26 VersandVersand innerhalb von USAAnzahl: 3 verfügbar
Zustand: As New. Unread book in perfect condition.
Aligning Investments in Therapeutic Development with Therapeutic Need
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes KönigreichPBShop.store UK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 25,81
EUR 4,86 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
- Softcover
Anbieter: Grand Eagle Retail, Bensenville, IL, USAGrand Eagle Retail
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 32,74
Versand gratisVersand innerhalb von USAAnzahl: 1 verfügbar
Paperback. Zustand: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment i…n pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Softcover
Anbieter: Chiron Media, Wallingford, Vereinigtes KönigreichChiron Media
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 22,18
EUR 18,08 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
paperback. Zustand: New.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 25,17
EUR 17,51 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 3 verfügbar
Zustand: New.
- Softcover
Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 27,21
EUR 17,51 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Paperback. Zustand: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Aligning Investments In Therapeutic Deve
National Academies Of Sciences, Engineering, And Medicine; Health And Medicine Division; Board Of Health Care Services; Committee On Strategies To Better Align Investments In Innovations For Therapeutic Development With Disease Burden And Unmet Needs
- Softcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 27,65
EUR 17,51 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 3 verfügbar
Zustand: As New. Unread book in perfect condition.
- Softcover
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandKennys Bookshop and Art Galleries Ltd.
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 37,07
EUR 9,50 VersandVersand von Irland nach USAAnzahl: 2 verfügbar
Zustand: New. 2025. paperback. . . . . .
- Softcover
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes KönigreichTHE SAINT BOOKSTORE
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 28,80
EUR 18,69 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Paperback / softback. Zustand: New. New copy - Usually dispatched within 3 working days.
- Softcover
Anbieter: Kennys Bookstore, Olney, MD, USAKennys Bookstore
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 45,20
EUR 8,98 VersandVersand innerhalb von USAAnzahl: 2 verfügbar
Zustand: New. 2025. paperback. . . . . . Books ship from the US and Ireland.
- Softcover
Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 47,72
EUR 17,51 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Paperback. Zustand: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
- Softcover
Anbieter: CitiRetail, Stevenage, Vereinigtes KönigreichCitiRetail
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 29,44
EUR 43,19 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Paperback. Zustand: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment i…n pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
- Softcover
Anbieter: AussieBookSeller, Truganina, VIC, AustralienAussieBookSeller
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 51,20
EUR 31,66 VersandVersand von Australien nach USAAnzahl: 1 verfügbar
Paperback. Zustand: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment i…n pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Softcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 35,15
EUR 61,93 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Taschenbuch. Zustand: Neu. Neuware - The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment…in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.
